These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11710576)

  • 21. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a reverse-phase HPLC with fluorescence detector method for simultaneous determination of CZ48 and its active metabolite camptothecin in mouse plasma.
    Liu X; Wang Y; Vardeman D; Cao Z; Giovanella B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):84-9. PubMed ID: 18396471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues.
    Li YF; Zhang R
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):257-65. PubMed ID: 8971608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrahigh-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) assay for simultaneous quantifications of CZ48, lactone-stabilized camptothecin, and camptothecin and their pharmacokinetic and biliary evaluations in rats.
    Kim YJ; Tu Y; Chow DS
    J Pharm Biomed Anal; 2018 Nov; 161():122-128. PubMed ID: 30149187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography determination of 10-hydroxycamptothecin in human serum by a column-switching system containing a pre-column with restricted access media and its application to a clinical pharmacokinetic study.
    Ma J; Jia ZP; Zhang Q; Fan JJ; Jiang NX; Wang R; Xie H; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):195-200. PubMed ID: 14552831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
    Rivory LP; Findlay M; Clarke S; Bishop J
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):355-9. PubMed ID: 9766876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles.
    Martins SM; Wendling T; Gonçalves VM; Sarmento B; Ferreira DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):100-7. PubMed ID: 22153332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitive high-performance liquid chromatographic method for the determination of the lactone form and the lactone plus hydroxy-acid forms of the new camptothecin derivative DX-8951 in human plasma using fluorescence detection.
    Oguma T; Ohshima Y; Nakaoka M
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):237-45. PubMed ID: 10821410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection.
    Oguma T; Konno T; Nakaoka M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 801(2):157-64. PubMed ID: 14751783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of camptothecin and 10-hydroxycamptothecin in human plasma using polymer monolithic in-tube solid phase microextraction combined with high-performance liquid chromatography.
    Wen Y; Fan Y; Zhang M; Feng YQ
    Anal Bioanal Chem; 2005 May; 382(1):204-10. PubMed ID: 15900473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of total and lactone form of a new camptothecin derivative gimatecan (ST1481) and its metabolite ST1698 in human plasma by high-performance liquid chromatography with fluorimetric detection.
    Pace S; Capocasa F; Tallarico C; Frapolli R; Zucchetti M; Longo A
    J Pharm Biomed Anal; 2009 Oct; 50(3):507-14. PubMed ID: 19553057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.
    de Bruijn P; de Jonge MJ; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Apr; 269(1):174-8. PubMed ID: 10094790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of irinotecan and its metabolite SN-38 in dried blood spots using high-performance liquid-chromatography with fluorescence detection.
    Hahn RZ; Arnhold PC; Andriguetti NB; Schneider A; Klück HM; Dos Reis SL; Bastiani MF; Kael I; da Silva ACC; Schwartsmann G; Antunes MV; Linden R
    J Pharm Biomed Anal; 2018 Feb; 150():51-58. PubMed ID: 29216585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.
    Oguma T; Konno T; Inaba A; Nakaoka M
    Biomed Chromatogr; 2001 Apr; 15(2):108-15. PubMed ID: 11268051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecin derivative, in human plasma and urine.
    Smith JA; Hausheer F; Newman RA; Madden TL
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):117-24. PubMed ID: 11499615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodegradation of irinotecan (CPT-11) in aqueous solutions: identification of fluorescent products and influence of solution composition.
    Dodds HM; Craik DJ; Rivory LP
    J Pharm Sci; 1997 Dec; 86(12):1410-6. PubMed ID: 9423156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokinetics.
    Upreti VV; Mamidi RN; Katneni K; Srinivas NR
    Biomed Chromatogr; 2003 Sep; 17(6):385-90. PubMed ID: 13680849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.
    Rosing H; Doyle E; Davies BE; Beijnen JH
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):107-15. PubMed ID: 7550966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection.
    Fraier D; Cenacchi V; Frigerio E
    J Chromatogr A; 1998 Feb; 797(1-2):295-303. PubMed ID: 9542121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T; Cheng J; Khin KT; Davis ME
    Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.